![How to Find Low-Competition Keywords with Semrush [Super Easy]](https://static.semrush.com/blog/uploads/media/73/62/7362f16fb9e460b6d58ccc09b4a048b6/how-to-find-low-competition-keywords-sm.png)
3 Magnificent Growth Stocks to Buy in March
It's often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up. We asked three Motley Fool contributors to pick slam-dunk growth stocks investors can confidently add to their portfolios. They chose three famous drugmakers: Eli Lilly (NYSE: LLY), Amgen (NASDAQ: AMGN), and Vertex Pharmaceuticals (NASDAQ: VRTX). Read on to discover why.Prosper Junior Bakiny (Eli Lilly): What's considered excellent revenue growth depends on the industry. For pharmaceutical companies, especially those with a market cap above $50 billion, year-over-year top-line increases in the high-single-digit percentages are already pretty strong. With that context in mind, consider that Eli Lilly's revenue growth has not dipped below 20% since mid-2023.Continue reading
It's often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up. We asked three Motley Fool contributors to pick slam-dunk growth stocks investors can confidently add to their portfolios. They chose three famous drugmakers: Eli Lilly (NYSE: LLY), Amgen (NASDAQ: AMGN), and Vertex Pharmaceuticals (NASDAQ: VRTX). Read on to discover why.
Prosper Junior Bakiny (Eli Lilly): What's considered excellent revenue growth depends on the industry. For pharmaceutical companies, especially those with a market cap above $50 billion, year-over-year top-line increases in the high-single-digit percentages are already pretty strong. With that context in mind, consider that Eli Lilly's revenue growth has not dipped below 20% since mid-2023.
